How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Gastric Cancer

Select Clinical Trial

Gastric Cancer

GS-US-296-1080: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined With mFOLFOX6 as First Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

  • Men and women, ages 18 and older, diagnosed with cancer of the stomach or gastroesophageal junction. For more information, please contact the study coordinator at 910-715-2200.
Clara McLean House
Make a Donation
News & Events